T-cell-dependent antibody response: assay development in cynomolgus monkeys

Area of Science:

• Immunology
• Pharmacology
• Toxicology

Background:

• Developing reliable immunogenicity assays is crucial for drug development.
• Cynomolgus monkeys are frequently used as preclinical models for immune response studies.

Purpose of the Study:

• To establish and validate a T-cell dependent antibody response model to keyhole limpet hemocyanin (KLH) in cynomolgus monkeys.
• To evaluate the immunosuppressive effects of cyclosporine on this model.
• To assess the impact of cyclosporine on various toxicity endpoints.

Main Methods:

• Monkeys received intramuscular injections of KLH to elicit an antibody response.
• Serum samples were analyzed for anti-KLH IgM and IgG titers.
• Cyclosporine was administered orally to assess its effects on antibody production and toxicity.
• Hematology, biochemistry, histopathology, and lymphocyte subset analysis were performed.

Main Results:

• A robust T-cell dependent antibody response to KLH was observed, with peak IgM and IgG titers at approximately 10-14 and 14-21 days, respectively.
• Cyclosporine treatment led to decreased IgG titers in some animals and mild lymphoid depletion in lymphoid tissues.
• No significant alterations in IgM production, hematology, biochemistry, bone marrow, organ weights, or peripheral lymphocyte subsets were observed with cyclosporine treatment.
• KLH immunization alone did not affect standard toxicity endpoints.

Conclusions:

• The study successfully established a KLH-induced antibody response model in cynomolgus monkeys.
• Cyclosporine demonstrated immunosuppressive activity by reducing IgG antibody production and causing lymphoid depletion.
• The model is suitable for evaluating drug-induced immunosuppression without confounding effects on general toxicity.